Registration Updates: Bioperfectus SARS-CoV-2 Antigen Rapid Test was Approved by the Ministry of Health Israel

Company news
2021-12-02

Bioperfectus is proud to announce that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test was approved by the Ministry of Health Israel. 

 

Registration information is now available on the Ministry of Health Israel website, click here to learn more>> 

 

 

MOST READ

Bioperfectus 2021 Special Review: Goodbye 2021, Hello 2022

2021 has been an exceptional year for Bioperfectus. We have successfully achieved many milestones by supplying our molecular diagnostic products to where people need them most. The glorious stories and moments shaped 2021 of Bioperfectus, now come and follow us for our special #2021Review.

2021-12-31

Bioperfectus Obtained CE Mark for the SARS-CoV-2 Antigen Rapid Self-test

Bioperfectus is pleased to announce that we have obtained CE Mark for our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test).

2021-12-28

Bioperfectus Launches a New RT-PCR Kit to Detect COVID-19 New Variant"Omicron"

As a leading manufacturer of molecular diagnostic solutions for infectious diseases, Biopertectus is very proud to announce today that the new SARS-CoV-2 Variant Omicron (B.1.1.529) Real-Time PCR Kit is launched globally. With the detection of the mutation sites of H655Y, N679K, P681H, and E484A, this new kit could help to identify the Omicron variant conveniently and effectively.

2021-12-27